| Literature DB >> 31371561 |
Jennifer S Chen1,2, Biyan Zhang1,2, Adam Williams3,4, Stephanie C Eisenbarth5,2, Uthaman Gowthaman1,2, William F Flynn6, Yisi Lu2, Wenzhi Song2, Julie Joseph1, Jake A Gertie1,2, Lan Xu1,2, Magalie A Collet6, Jessica D S Grassmann6, Tregony Simoneau7, David Chiang8, M Cecilia Berin8, Joseph E Craft2, Jason S Weinstein9.
Abstract
Cross-linking of high-affinity immunoglobulin E (IgE) results in the life-threatening allergic reaction anaphylaxis. Yet the cellular mechanisms that induce B cells to produce IgE in response to allergens remain poorly understood. T follicular helper (TFH) cells direct the affinity and isotype of antibodies produced by B cells. Although TFH cell-derived interleukin-4 (IL-4) is necessary for IgE production, it is not sufficient. We report a rare population of IL-13-producing TFH cells present in mice and humans with IgE to allergens, but not when allergen-specific IgE was absent or only low-affinity. These "TFH13" cells have an unusual cytokine profile (IL-13hiIL-4hiIL-5hiIL-21lo) and coexpress the transcription factors BCL6 and GATA3. TFH13 cells are required for production of high- but not low-affinity IgE and subsequent allergen-induced anaphylaxis. Blocking TFH13 cells may represent an alternative therapeutic target to ameliorate anaphylaxis.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31371561 DOI: 10.1126/science.aaw6433
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728